ARC Desk

Pharmacovigilance Outsourcing Market to Grow at 16% of CAGR By 2026

Lehdistötiedote   •   Elo 26, 2019 13:00 EEST

According to Acumen Research and Consulting, The global market for Pharmacovigilance Outsourcing is expected to grow at a CAGR of roughly 16% during the forecast period 2018 to 2026.

Market Overview:

Pharmacovigilance Outsourcing Market 2018 - 2026 research report includes the SWOT analysis that's Strengths, Weakness, Opportunities and Threats which provides you complete analysis of competitors, market growth, market share and in addition as CAGR comparison by region. The report provides analysis of the global Pharmacovigilance Outsourcing Market for the period from 2016 to 2026, wherein 2018–2026 is the forecast period and 2018 is the base year. Data for 2017 has been included as historical information.

The report covers all trends and technologies expected to play a major role in growth of the global Pharmacovigilance Outsourcing Market during the forecast period. It highlights drivers, restraints, and opportunities expected to influence the market from 2018 to 2026. The study provides a holistic perspective on the Pharmacovigilance Outsourcing Market, in terms of revenue (in US$ Mn) and volume (in million units), across different regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America. The report highlights key trends affecting the Pharmacovigilance Outsourcing Market at the global level. Prominent countries/sub-regions covered in the report include the U.S., Canada, Germany, France, the U.K., Italy, Russia, India, China, Japan, South Korea, South East Asia, GCC, South Africa, and Brazil.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1094

The report comprises detailed ecosystem analysis, which provides a comprehensive view of the global Pharmacovigilance Outsourcing Market. Porter’s five forces model has also been included to help understand the competition landscape of the market. Additionally, current indicators of diverse macro-economic factors are contextualized under key market indicators.

The report also analyzes the Pharmacovigilance Outsourcing Market on the basis of various segments. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Scope of the Pharmacovigilance Outsourcing Market Report:

The study provides a decisive view of the Pharmacovigilance Outsourcing Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Segmentation:

Market, By Service

  • Pre-marketing services
    • Clinical pharmacovigilance services
    • Case processing services
    • Safety data management services
    • Medical review
  • Post-marketing services
    • Knowledge process outsourcing services
    • IT solutions and services
  • Others

Market, By Service Provider

  • Contract research organizations (CROs)
  • Business process outsourcing (BPOs)

Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on “Pharmacovigilance Outsourcing Market (By Service: Pre-marketing services [Clinical pharmacovigilance services, Case processing services, Safety data management services, Medical review], Post-marketing services [Knowledge process outsourcing services, IT solutions and services], Others; By Service Provider: Contract research organizations (CROs), Business process outsourcing (BPOs)) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers a detailed insights on global pharmacovigilance outsourcing market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global pharmacovigilance outsourcing market by service, service providers, fuel, distribution channel and major geographic regions. The report also covers basic drug development policies.

Market Participants / Key Players:

The global pharmacovigilance outsourcing market is characterized by the presence of experienced and established players. Some of the key players include Bioclinica, Clintec, Covance, Medpace Holdings, Oracle Corporation, iGATE Corporation, Accenture, iMED Global Corporation, Symogen, Ergomed, IBM Corporation, IQVIA, MarksMan Healthcare, Parexel, SIRO Clinpharm and Novartis. Various prominent players from the market are entering into strategic acquisitions in order to offer advanced pharmacovigilance outsourcing technologies to their clients. Additionally, they are focusing on strategic acquisitions in order to expand their industry presence.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Research Methodology

Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, SEC filings, internal and external proprietary databases, relevant patent and regulatory databases, national government documents, statistical databases, market reports, news articles, press releases, webcasts specific to companies operating in the market, national government documents, statistical databases, and Factiva.

Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews conducted for each market segment across geographies. ARC conducts primary interviews on an ongoing basis with market participants and commentators in order to validate the data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competition landscape, and market outlook. These help validate and strengthen secondary research findings. They also help develop the analysis team’s expertise and market understanding. 

VIEW FULL RESEARCH REPORT@ https://www.acumenresearchandconsulting.com/pharmacovigilance-outsourcing-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Pharmacovigilance Outsourcing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Pharmacovigilance Outsourcing Market By Service
1.2.2.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service (2015-2026)
1.2.2.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service in 2017
1.2.2.3. Pre-marketing services
1.2.2.4. Post-marketing services
1.2.2.5. Others
1.2.3. Pharmacovigilance Outsourcing Market By Service Provider
1.2.3.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service Provider (2015-2026)
1.2.3.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service Provider in 2017
1.2.3.3. Contract research organizations (CROs)
1.2.3.4. Business process outsourcing (BPOs)
1.2.3.5. Others
1.2.4. Pharmacovigilance Outsourcing Market by Geography
1.2.4.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017

CHAPTER 4. PHARMACOVIGILANCE OUTSOURCING MARKET BY SERVICE

4.1. Global Pharmacovigilance Outsourcing Revenue By Service
4.2. Pre-marketing services
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Post-marketing services
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. PHARMACOVIGILANCE OUTSOURCING MARKET BY SERVICE PROVIDER

5.1. Global Pharmacovigilance Outsourcing Revenue By Service Provider
5.2. Contract research organizations (CROs)
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Business process outsourcing (BPOs)
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

6.1. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Pharmacovigilance Outsourcing Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

7.1. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

8.1. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

9.1. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

10.1. Middle East Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

11.1. Africa Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Bioclinica
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Clintec
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Covance
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Medpace Holdings
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Oracle Corporation
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. iGATE Corporation
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Accenture
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. iMED Global Corporation
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Symogen
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Ergomed
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. IBM Corporation
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. IQVIA
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. MarksMan Healthcare
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies
12.14. Parexel
12.14.1. Company Snapshot
12.14.2. Overview
12.14.3. Financial Overview
12.14.4. Product Portfolio
12.14.5. Key Developments
12.14.6. Strategies
12.15. SIRO Clinpharm
12.15.1. Company Snapshot
12.15.2. Overview
12.15.3. Financial Overview
12.15.4. Product Portfolio
12.15.5. Key Developments
12.15.6. Strategies
12.16. Novartis
12.16.1. Company Snapshot
12.16.2. Overview
12.16.3. Financial Overview
12.16.4. Product Portfolio
12.16.5. Key Developments
12.16.6. Strategies
12.17. Others
12.17.1. Company Snapshot
12.17.2. Overview
12.17.3. Financial Overview
12.17.4. Product Portfolio
12.17.5. Key Developments
12.17.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1094

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.